Breaking News, Financial News

Financial Report: Patheon

Revenues from commercial manufacturing operations were $138.5 million (-3%) in the quarter.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

2Q Revenues: $170.0 million (-3%)

2Q Loss: $11.2 million (earnings were $10.9 million in 2Q10)

YTD Revenues: $345.7 million (+5%)

YTD Loss: $10.7 million (loss of $0.2 million YTD10)

Comments: Revenues from commercial manufacturing operations were $138.5 million (-3%) in the quarter. Pharmaceutical Development Services (PDS) revenue was $31.5 million (-5%). Results in the quarter reflect contract cancellations and delays in the PDS business and an $8.8 million negative currency impact.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters